MedMen Enterprises Inc. (MMNFF)
| Previous Close | 0.0901 |
| Open | 0.0865 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0850 - 0.1000 |
| 52 Week Range | 0.0840 - 0.4400 |
| Volume | |
| Avg. Volume | 2,011,015 |
| Market Cap | 112.634M |
| Beta (5Y Monthly) | 1.37 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1420 |
| Earnings Date | May 20, 2022 - May 23, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.32 |
- Business Wire
MedMen to Sell New York Operations for $88 Million; $15 Million Incremental Value
LOS ANGELES, May 11, 2022--MedMen Enterprises Inc. ("MedMen" or the "Company") (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis retailer with operations across the United States, today announced a definitive agreement with Ascend Wellness Holdings ("AWH") that will allow the sale of MedMen’s New York operations to close for increased consideration. The transaction resolves the litigation between MedMen and AWH concerning the transaction and delivers $15 million in additional value to MedMen shareh
- Business Wire
MedMen Announces Edward Record as CEO
LOS ANGELES, April 27, 2022--MedMen Announces Edward Record as CEO
- Business Wire
MedMen Announces Partial Adjournment of Annual and Special Meeting of Shareholders until May 19, 2022
LOS ANGELES, April 26, 2022--MedMen Enterprises Inc. ("MedMen" or the "Company") (CSE: MMEN) (OTCQX: MMNFF), a premier American cannabis retailer, today announced the partial adjournment of its 2022 Annual and Special Meeting of Shareholders ("Annual Meeting"), with respect to Proposal 3, set forth in its Definitive Proxy Statement filed with the U.S. Securities and Exchange Commission on March 11, 2022 (the "Proxy Statement") until May 19, 2022 at 9:00 AM (Pacific Time). The Annual Meeting was
